{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/ARQT/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-23T01:26:40.112Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":1856,"canonical_name":"Arcutis Biotherapeutics, Inc.","cik":"0001787306","uei":null,"lei":null,"duns":null,"ticker":"ARQT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"fda":1,"sec":41,"open":1},"count":43,"timeline":[{"ts":"20260702","kind":"fda.label","reporter":"Arcutis Biotherapeutics, Inc.","title":"ZORYVE","security_title":"ROFLUMILAST","excerpt":"1 INDICATIONS AND USAGE ZORYVE cream is a phosphodiesterase 4 inhibitor: Plaque Psoriasis ZORYVE cream, 0.3%, is indicated for the topical treatment of plaque psoriasis, including intertriginous areas","accession_number":"ec1bb0d1-f38a-4080-831a-68791d1d1fdb","route":"TOPICAL","product_type":"HUMAN PRESCRIPTION DRUG","importance":30},{"ts":"2026-08-11","kind":"sec.form144","reporter":"Patrick Burnett","title":"Officer","shares":15000,"usd_value":397824,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001628280-26-055797","importance":40.0795648},{"ts":"2026-08-03","kind":"sec.insider.4375","reporter":"Watanabe Todd","title":"See Remarks","shares":4375,"price_per_share":26.1168,"usd_value":114261,"security_title":"Common Stock","importance":15.114261},{"ts":"2026-08-03","kind":"sec.insider.1230","reporter":"Matsuda Masaru","title":"See Remarks","shares":1230,"price_per_share":26.1168,"usd_value":32124,"security_title":"Common Stock","importance":15.032123664},{"ts":"2026-08-03","kind":"sec.insider.955","reporter":"Burnett Patrick","title":"See Remarks","shares":955,"price_per_share":26.1168,"usd_value":24942,"security_title":"Common Stock","importance":15.024941544},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Arcutis Biotherapeutics, Inc. — 2026-07-17","url_slug":"/sec/cik-0001787306/4/0001628280-26-048641","accession_number":"0001628280-26-048641","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Arcutis Biotherapeutics, Inc. — 2026-07-16","url_slug":"/sec/cik-0001787306/8-k/0001628280-26-048469","accession_number":"0001628280-26-048469","importance":35},{"ts":"2026-07-15","kind":"sec.form144","reporter":"Howard Welgus","title":"Director","shares":4730,"usd_value":127284,"security_title":"Common","approx_sale_date":"2026-07-15","accession_number":"0001628280-26-048326","importance":40.02545686},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Welgus Howard G.","title":"","shares":4730,"price_per_share":26.91,"usd_value":127284,"security_title":"Common Stock","importance":35.1272843},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Welgus Howard G.","title":"","shares":2255,"price_per_share":8.63,"usd_value":19461,"security_title":"Common Stock","importance":15.01946065},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Welgus Howard G.","title":"","shares":1019,"price_per_share":7.51,"usd_value":7653,"security_title":"Common Stock","importance":15.00765269},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Welgus Howard G.","title":"","shares":822,"price_per_share":6.5223,"usd_value":5361,"security_title":"Common Stock","importance":15.0053613306},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Peetz Christopher","title":null,"shares":4315,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Howard Welgus","title":"Director","shares":635,"usd_value":16300,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001628280-26-043877","importance":40.00326009},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Welgus Howard G.","title":"","shares":635,"price_per_share":25.67,"usd_value":16300,"security_title":"Common Stock","importance":35.01630045},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — Arcutis Biotherapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001787306/144/0001628280-26-043877","accession_number":"0001628280-26-043877","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Arcutis Biotherapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001787306/4/0001628280-26-044079","accession_number":"0001628280-26-044079","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Arcutis Biotherapeutics, Inc. — 2026-06-17","url_slug":"/sec/cik-0001787306/4/0001628280-26-044083","accession_number":"0001628280-26-044083","importance":30},{"ts":"2026-06-15","kind":"sec.form144","reporter":"Sue-Jean Lin","title":"Officer","shares":4946,"usd_value":120587,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001628280-26-043183","importance":40.024117358},{"ts":"2026-06-15","kind":"sec.form144","reporter":"Howard Welgus","title":"Director","shares":4096,"usd_value":99980,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001628280-26-043178","importance":40.019996098},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"LIN SUE-JEAN","title":null,"shares":4946,"price_per_share":24.3807,"usd_value":120587,"security_title":"Common Stock","importance":35.1205869422},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Welgus Howard G.","title":"","shares":4096,"price_per_share":24.4093,"usd_value":99980,"security_title":"Common Stock","importance":35.0999804928},{"ts":"2026-06-15","kind":"sec.filing","form_type":"144","title":"144 — Arcutis Biotherapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001787306/144/0001628280-26-043178","accession_number":"0001628280-26-043178","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"144","title":"144 — Arcutis Biotherapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001787306/144/0001628280-26-043183","accession_number":"0001628280-26-043183","importance":30},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Welgus Howard G.","title":"","shares":2255,"price_per_share":8.63,"usd_value":19461,"security_title":"Common Stock","importance":15.01946065},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Welgus Howard G.","title":"","shares":1019,"price_per_share":7.51,"usd_value":7653,"security_title":"Common Stock","importance":15.00765269},{"ts":"2026-06-15","kind":"sec.insider.m","reporter":"Welgus Howard G.","title":"","shares":822,"price_per_share":6.5223,"usd_value":5361,"security_title":"Common Stock","importance":15.0053613306},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — Arcutis Biotherapeutics, Inc. — 2026-06-09","url_slug":"/sec/cik-0001787306/4/0001628280-26-042039","accession_number":"0001628280-26-042039","importance":30},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"Heron Patrick J","title":"","shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"Leonard Keith R","title":null,"shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"Krishnamohan Neha","title":null,"shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"LIN SUE-JEAN","title":null,"shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"Welgus Howard G.","title":"","shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"Gilbert Halley E","title":"","shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"Munshi Amit","title":null,"shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.a","reporter":"Curran Terrie","title":null,"shares":5778,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-13","kind":"sec.filing","form_type":"4","title":"4 — Arcutis Biotherapeutics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001787306/4/0002065881-26-000004","accession_number":"0002065881-26-000004","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Arcutis Biotherapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001787306/schedule-13g/0000093751-26-000207","accession_number":"0000093751-26-000207","importance":55},{"ts":"2026-05-12","kind":"sec.13dg","reporter":"Arcutis Biotherapeutics, Inc.","shares":6296197,"percent_of_class":5.1,"security_title":"SCHEDULE 13G","accession_number":"0000093751-26-000207","excerpt":null,"importance":55},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"Vairavan Latha","title":"SVP Chief Financial Officer","shares":435,"price_per_share":21.05,"usd_value":9157,"security_title":"Common Stock","importance":35.00915675},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"Burnett Patrick","title":"See Remarks","shares":222,"price_per_share":21.05,"usd_value":4673,"security_title":"Common Stock","importance":35.0046731},{"ts":"2026-05-08","kind":"sec.13dg","reporter":"PRUDENTIAL FINANCIAL INC","shares":5302713,"percent_of_class":4.3,"security_title":"SCHEDULE 13G/A","accession_number":"0001137774-26-000098","excerpt":null,"importance":55},{"ts":"2024-12-31","kind":"open.payments","reporter":"Arcutis Biotherapeutics, Inc.","title":"$5024975.0 to 9751 physicians (2024–2024)","security_title":"manufacturer","excerpt":"Zoryve","accession_number":"2024","usd_value":5024975,"importance":70}]}